Sarepta Therapeutics, Inc. SRPT Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s change in other assets?
- Sarepta Therapeutics, Inc. (SRPT) reported change in other assets of $14.55M in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s change in other assets changed year-over-year?
- Sarepta Therapeutics, Inc.'s change in other assets decreased by 3.5% year-over-year, from $15.07M to $14.55M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s change in other assets?
- Over 2 years (2021 to 2023), Sarepta Therapeutics, Inc.'s change in other assets has grown at a -86.8% compound annual growth rate (CAGR), from -$103.2M to -$1.81M.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.